Use and interpretation of HbA(1c) testing in general practice. Implications for quality of care

We evaluate the interpretation and use of HbA(1c) results in general practi ce in relation to diabetes follow-up and case-finding. As part of an extern al quality assurance scheme for laboratory analyses, two case histories wer e mailed to all Norwegian GPs with equipment for HbA(1c) analysis in their office laboratory (n=566) and to a random sample of GPs without such instru ments (n=419). Patient A represented a monitoring situation and the GPs wer e asked to state changes in HbA(1c) signifying any improvement or deteriora tion of metabolic control. The initial HbA(1c) value stemmed from analysis of quality control material in the instrument group and was a preset value for the other group. In patient B, we focused on the use of HbA(1c) and oth er laboratory tests in diabetes case-finding. In the monitoring situation, 22% of GPs in the instrument group misclassified changes in HbA(1c) values, since these were less than the analytical uncertainty. Further, when inter preting HbA(1c) results, 64-93% of GPs (i) assumed that analytical quality was better than it really was, (ii) did not appreciate biological variation of HbA(1c), or (iii) acted on small differences to be on the safe side. In case-finding, HbA(1c) was deemed important by 29% of GPs; doctors choosing not to perform a glucose tolerance test relied more on HbA(1c). GPs have t o be aware of analytical quality and biological variation when interpreting HbA(1c) results. The present limitations of HbA(1c) in the diagnosis of di abetes are not properly understood.